googlemarker
Open An Account
Secure With Us
Refer a Friend
Trade on Mobile

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 371951.96 Face Value (Rs.) : 2 House : Cipla
BSE461.350.75 (+0.16 %)
PREV CLOSE (Rs.) 460.60
OPEN PRICE (Rs.) 462.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 47653
TODAY'S LOW / HIGH (Rs.)456.55 464.80
52 WK LOW / HIGH (Rs.)389.55 585.5
NSE461.250.2 (+0.04 %)
PREV CLOSE( Rs. ) 461.05
OPEN PRICE (Rs.) 461.05
BID PRICE (QTY) 461.25 (637)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1213599
TODAY'S LOW / HIGH(Rs.) 456.60 465.00
52 WK LOW / HIGH (Rs.)389.55 586
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
219.68
Dividend Yield(%)
0.65
TTM EPS (Rs.)
29.28
P/E Ratio
15.76
Book Value (Rs.)
209.72
Face Value (Rs.)
2
MCap (Rs. in Mn)
371951.96
Price/Earning (TTM)
12.61
Price/Sales (TTM)
3.00
Price/Book (MRQ)
2.20
PAT Margin (%)
14.48
ROCE (%)
16.69
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 022-24826951

Website : www.cipla.com

Registrars Details :

KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
12Dec Announcement under Regulation 30 (LOD
Please find enclosed press release dated 11th December, 2019 by Avenue T..
12Dec Cipla, Maruti Suzuki and Kotak Mahindr
Avenue Therapeutics, an associate company of Cipla has submitted a New D..
12Dec Cipla’s associate company submits NDA
Avenue Therapeutics, an associate company of Cipla, has submitted a New..
QTR Sep 19 ANNUAL 19
Net Profit7373.8000000000118884.1
Gross Profit 9199.00000000001 24928.3
Operating Profit 10807 30795.2
Net Sales 33701.8 123740.1
Rs. in Millions
Abbott India (BSE)
img  12973.85 (1.19%)
M.Cap (Rs. in Cr)27623.88
Sanofi India (BSE)
img  6974.00 (0.92%)
M.Cap (Rs. in Cr)16061.56
Astrazeneca Pharma I (BSE)
img  2819.40 (2.26%)
M.Cap (Rs. in Cr)7044.50
Pfizer (BSE)
img  4333.10 (1.20%)
M.Cap (Rs. in Cr)20034.08
PROMOTERS
36.68%
NON-INSTITUTION
21.53%
MUTUAL FUNDS/UTI
13.24%
FI/BANKS/INSURANCE
4.18%
FII
0.57%
GOVERNMENT
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ000198838  | 
  • BSE- INZ000198838  | 
  • MCX- INZ000198838  | 
  • NCDEX- INZ000198838  | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     1730859